Locations:
Search
Phase 1 trial outcomes offer encouraging news for developing targeted therapy for solid tumors
Cleveland Clinic to administer first-of-its-kind T-cell therapy
Molecular Profiles Help Guide Referral and Care Planning
Heavily pretreated patients experience improved progression-free survival and quality of life with CD20xCD3 therapy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The rare and aggressive form of bone cancer requires specialized treatment, but new and emerging therapies are providing hope for patients
Innovative procedure reduces scarring, recovery time and nipple sensation
Leaning into therapies with the strongest evidence
Best practices for supporting patients with honesty and compassion
Study uses molecular and clinical stratification to help guide patient selection
Phase 3 STELLAR trial underscores role of molecular stratification in glioma care
Advertisement
Advertisement